December 2025 FDA Recall Drug by Central Admixture Pharmacy Services, Inc (caps) Los Angeles (D-0524-2026 - Incorrect Product Formulation)

This Class II drug recall was voluntarily initiated by Central Admixture Pharmacy Services, Inc (caps) Los Angeles on December 27, 2025 for the product Drug. The FDA reported the reason for recall as incorrect product formulation. The product was distributed in CA and the recall is currently ongoing.

Recall Number: D-0524-2026

Reason for Recall
Incorrect Product Formulation: product did not contain insulin as listed in the label.
Initiated
12-27-2025
Reported
05-13-2026
Quantity
1 bag

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles
TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume 1660 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection, Central Admixture Pharmacy Services, Los Angeles, 13128 Imperial Hwy, Santa Fe Spr., CA 90670

Batch or Lot Expiration Information

Lot# : 11-4909703-0-1, Exp 12/28/2025